# Down Sizing Strategy (HANGZHOU Solution) vs Standard Sizing Strategy TAVR in Bicuspid Aortic Stenosis (Type 0)

> **NCT05511792** · NA · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 206 (estimated)

## Conditions studied

- Aortic Stenosis With Bicuspid Valve

## Interventions

- **PROCEDURE:** TAVR for BAV Using Down Sizing with the Evolut Pro platform
- **PROCEDURE:** TAVR for BAV Using Traditional Sizing strategy with the Evolut Pro platform

## Key facts

- **NCT ID:** NCT05511792
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-27
- **Primary completion:** 2026-07-30
- **Final completion:** 2030-06-30
- **Target enrollment:** 206 (ESTIMATED)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05511792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05511792, "Down Sizing Strategy (HANGZHOU Solution) vs Standard Sizing Strategy TAVR in Bicuspid Aortic Stenosis (Type 0)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05511792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*